Polycythemia vera: historical oversights, diagnostic details, and therapeutic views von Tefferi, Ayalew, Vannucchi, Alessandro M., Barbui, Tiziano

Volltext

How I treat polycythemia vera von Vannucchi, Alessandro M.

Volltext

Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia von Rotunno, Giada, Mannarelli, Carmela, Guglielmelli, Paola, Pacilli, Annalisa, Pancrazzi, Alessandro, Pieri, Lisa, Fanelli, Tiziana, Bosi, Alberto, Vannucchi, Alessandro M.

Volltext

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion von Barbui, Tiziano, Thiele, Jürgen, Gisslinger, Heinz, Kvasnicka, Hans Michael, Vannucchi, Alessandro M., Guglielmelli, Paola, Orazi, Attilio, Tefferi, Ayalew

Volltext

The dosage of ropeginterferon in polycythaemia vera: Balancing efficacy, safety and pharmacoeconomics across risk categories von Barbui, Tiziano, Tefferi, Ayalew, Vannucchi, Alessandro M

Volltext

MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis von Tefferi, Ayalew, Guglielmelli, Paola, Lasho, Terra L, Gangat, Naseema, Ketterling, Rhett P, Pardanani, Animesh, Vannucchi, Alessandro M

Volltext

Current management strategies for polycythemia vera and essential thrombocythemia von Guglielmelli, Paola, Vannucchi, Alessandro M.

Volltext

Emerging treatments for classical myeloproliferative neoplasms von Vannucchi, Alessandro M., Harrison, Claire N.

Volltext

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis von Tefferi, Ayalew, Guglielmelli, Paola, Larson, Dirk R., Finke, Christy, Wassie, Emnet A., Pieri, Lisa, Gangat, Naseema, Fjerza, Rajmonda, Belachew, Alem A., Lasho, Terra L., Ketterling, Rhett P., Hanson, Curtis A., Rambaldi, Alessandro, Finazzi, Guido, Thiele, Juergen, Barbui, Tiziano, Pardanani, Animesh, Vannucchi, Alessandro M.

Volltext

Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study von Passamonti, Francesco, Prof, Griesshammer, Martin, Prof, Palandri, Francesca, MD, Egyed, Miklos, Prof, Benevolo, Giulia, MD, Devos, Timothy, Prof, Callum, Jeannie, FRCPC, Vannucchi, Alessandro M, Prof, Sivgin, Serdar, MD, Bensasson, Caroline, PhD, Khan, Mahmudul, PhD, Mounedji, Nadjat, MD, Saydam, Guray, Prof

Volltext

Pegasus causes inherited thrombocytopenia von Vannucchi, Alessandro M.

Volltext

CALR mutations possess unique prognostic relevance in myelofibrosis—before and after transplant von Tefferi, Ayalew, Vannucchi, Alessandro M.

Volltext

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera von Vannucchi, Alessandro M, Kiladjian, Jean Jacques, Griesshammer, Martin, Masszi, Tamas, Durrant, Simon, Passamonti, Francesco, Harrison, Claire N, Pane, Fabrizio, Zachee, Pierre, Mesa, Ruben, He, Shui, Jones, Mark M, Garrett, William, Li, Jingjin, Pirron, Ulrich, Habr, Dany, Verstovsek, Srdan

Volltext

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis von Tefferi, Ayalew, Guglielmelli, Paola, Nicolosi, Maura, Mannelli, Francesco, Mudireddy, Mythri, Bartalucci, Niccolo, Finke, Christy M., Lasho, Terra L., Hanson, Curtis A., Ketterling, Rhett P., Begna, Kebede H., Naseema Gangat, Pardanani, Animesh, Vannucchi, Alessandro M.

Volltext

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis) von Barbui, Tiziano, Finazzi, Guido, Carobbio, Alessandra, Thiele, Juergen, Passamonti, Francesco, Rumi, Elisa, Ruggeri, Marco, Rodeghiero, Francesco, Randi, Maria Luigia, Bertozzi, Irene, Gisslinger, Heinz, Buxhofer-Ausch, Veronika, De Stefano, Valerio, Betti, Silvia, Rambaldi, Alessandro, Vannucchi, Alessandro M., Tefferi, Ayalew

Volltext

Risk models in myelofibrosis—the past, present, and future von Tefferi, Ayalew, Vannucchi, Alessandro M.

Volltext

MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis von Guglielmelli, Paola, Lasho, Terra L, Rotunno, Giada, Mudireddy, Mythri, Mannarelli, Carmela, Nicolosi, Maura, Pacilli, Annalisa, Pardanani, Animesh, Rumi, Elisa, Rosti, Vittorio, Hanson, Curtis A, Mannelli, Francesco, Ketterling, Rhett P, Gangat, Naseema, Rambaldi, Alessandro, Passamonti, Francesco, Barosi, Giovanni, Barbui, Tiziano, Cazzola, Mario, Vannucchi, Alessandro M, Tefferi, Ayalew

Volltext

JAK2 inhibitor treatment of anemia in myelofibrosis von Tefferi, Ayalew, Vannucchi, Alessandro M.

Volltext

Effect of Mutation Order on Myeloproliferative Neoplasms von Ortmann, Christina A, Kent, David G, Nangalia, Jyoti, Silber, Yvonne, Wedge, David C, Grinfeld, Jacob, Baxter, E. Joanna, Massie, Charles E, Papaemmanuil, Elli, Menon, Suraj, Godfrey, Anna L, Dimitropoulou, Danai, Guglielmelli, Paola, Bellosillo, Beatriz, Besses, Carles, Döhner, Konstanze, Harrison, Claire N, Vassiliou, George S, Vannucchi, Alessandro, Campbell, Peter J, Green, Anthony R

Volltext

Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives von Loscocco, Giuseppe G., Vannucchi, Alessandro M.

Volltext